In colorectal cancer (CRC), ASX has demonstrated anti-migratory and anti-invasive activity by increasing miR-29a-3p and miR-200a expression, suppressing MMP2 and ZEB1 expression, resulting in the repression of the epithelial–mesenchymal transition (EMT) of CRC cells [53]. Here, MMP2 is linked to colorectal carcinoma.